Physician profile
Julia Glaser
NPI 1912346784
$16,974.95
in general payments reported to CMS, 2019-2025
21 companies · $4,250 in 2025
The $4,250 reported for 2025 was more than what 83% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,756 · 2020: $563 · 2021: $14.21 · 2022: $6,715 · 2023: $1,753 · 2024: $922 · 2025: $4,250.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,100 · Food and Beverage: $2,980 · Travel and Lodging: $846.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,100.00 |
| Food and Beverage | $2,980.20 |
| Travel and Lodging | $846.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $4,252.60 | 2020-2025 | Enroute Transcarotid Neuroprotection System, General - Metallic Stents, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Endologix LLC | $3,835.19 | 2019-2025 | Endocross Device, Torus Stent Graft System, Alto Abdominal Stent Graft System |
| Novartis Pharmaceuticals Corporation | $3,214.78 | 2025 | |
| Bolton Medical INC | $2,596.80 | 2019-2025 | Relay Thoracic Stent-Graft With Plus Delivery System |
| W. L. Gore & Associates, INC. | $1,506.80 | 2019-2025 | Gore Viabahn Vbx Balloon Expandable Endo |
| Silk Road Medical, INC. | $355.76 | 2022-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Veryan Medical Incorporated | $269.52 | 2023 | Biomimics 3d Vascular Stent System |
| Smith+Nephew, INC. | $188.13 | 2024-2025 | Oasis Micro, Stravix Pl, Grafix Pl |
| Baxter Healthcare | $155.82 | 2024 | Preveleak |
| Getinge USA Sales, LLC | $142.23 | 2019 | |
| Limflow INC. | $105.46 | 2023 | Limflow System |
| Cardinal Health 200 LLC | $85.71 | 2019 | |
| Janssen Pharmaceuticals, INC | $73.49 | 2022-2024 | Xarelto |
| Stryker Corporation | $55.84 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Amgen INC. | $27.00 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $24.90 | 2019 | |
| Medtronic, INC. | $22.25 | 2024 | Endurant Iis |
| Terumo Medical Corporation | $17.71 | 2019 | |
| Angiodynamics, INC. | $17.14 | 2022 | |
| Kerecis Limited | $15.99 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Integra Lifesciences Corporation | $11.83 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julia Glaser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.